Literature DB >> 16981854

MEGF9: a novel transmembrane protein with a strong and developmentally regulated expression in the nervous system.

Ulrike Brandt-Bohne1, Douglas R Keene, Fletcher A White, Manuel Koch.   

Abstract

MEGF9 [multiple EGF (epidermal growth factor)-like-domains 9], a novel transmembrane protein with multiple EGF-like repeats, is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present. The protein was recombinantly expressed and characterized as a tissue component. To study the expression pattern further, immunohistochemistry was performed and staining was detected in Purkinje cells of the cerebellum and in glial cells of the PNS. Additional expression was observed in the epidermal layer of skin, papillae of the tongue and the epithelium of the gastrointestinal tract. By immunoelectron microscopy, MEGF9 was detected in glial cells of the sciatic nerve facing the basement membrane. MEGF9 represents a novel putative receptor, expressed in neuronal and non-neuronal tissues, that is regulated during development and could function as a guidance or signalling molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16981854      PMCID: PMC1820795          DOI: 10.1042/BJ20060691

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

Review 1.  The structure and assembly of secreted mucins.

Authors:  J Perez-Vilar; R L Hill
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

2.  CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand.

Authors:  Talin Haritunians; Jim Boulter; Carol Hicks; Jonathon Buhrman; Guy DiSibio; Carrie Shawber; Gerry Weinmaster; Donna Nofziger; Carolyn Schanen
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

3.  An alternatively spliced Muc10 glycoprotein ligand for putative L-selectin binding during mouse embryonic submandibular gland morphogenesis.

Authors:  M Melnick; H Chen; Y Zhou; T Jaskoll
Journal:  Arch Oral Biol       Date:  2001-08       Impact factor: 2.633

4.  Porcine submaxillary mucin contains a cystine-rich, carboxyl-terminal domain in addition to a highly repetitive, glycosylated domain.

Authors:  A E Eckhardt; C S Timpte; J L Abernethy; Y Zhao; R L Hill
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

Review 5.  Notch signaling, brain development, and human disease.

Authors:  Joseph L Lasky; Hong Wu
Journal:  Pediatr Res       Date:  2005-04-06       Impact factor: 3.756

6.  Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene.

Authors:  M Kusakabe; L Mangiarini; E D Laywell; G P Bates; A Yoshiki; N Hiraiwa; J Inoue; D A Steindler
Journal:  J Comp Neurol       Date:  2001-02-19       Impact factor: 3.215

7.  Jagged-1 mutation analysis in Italian Alagille syndrome patients.

Authors:  G Pilia; M Uda; D Macis; F Frau; L Crisponi; F Balli; C Barbera; C Colombo; T Frediani; R Gatti; R Iorio; M G Marazzi; M Marcellini; S Musumeci; G Nebbia; P Vajro; G Ruffa; L Zancan; A Cao; S DeVirgilis
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

8.  Genetic and molecular characterization of a Notch mutation in its Delta- and Serrate-binding domain in Drosophila.

Authors:  J F de Celis; R Barrio; A del Arco; A García-Bellido
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Altered midline axon pathways and ectopic neurons in the developing hypothalamus of netrin-1- and DCC-deficient mice.

Authors:  M S Deiner; D W Sretavan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

10.  A novel member of the netrin family, beta-netrin, shares homology with the beta chain of laminin: identification, expression, and functional characterization.

Authors:  M Koch; J R Murrell; D D Hunter; P F Olson; W Jin; D R Keene; W J Brunken; R E Burgeson
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  11 in total

1.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.

Authors:  Aurélien A Sérandour; Stéphane Avner; Frédéric Percevault; Florence Demay; Maud Bizot; Céline Lucchetti-Miganeh; Frédérique Barloy-Hubler; Myles Brown; Mathieu Lupien; Raphaël Métivier; Gilles Salbert; Jérôme Eeckhoute
Journal:  Genome Res       Date:  2011-01-13       Impact factor: 9.043

2.  A Novel Approach to Single Cell RNA-Sequence Analysis Facilitates In Silico Gene Reporting of Human Pluripotent Stem Cell-Derived Retinal Cell Types.

Authors:  M Joseph Phillips; Peng Jiang; Sara Howden; Patrick Barney; Jee Min; Nathaniel W York; Li-Fang Chu; Elizabeth E Capowski; Abigail Cash; Shivani Jain; Katherine Barlow; Tasnia Tabassum; Ron Stewart; Bikash R Pattnaik; James A Thomson; David M Gamm
Journal:  Stem Cells       Date:  2017-12-25       Impact factor: 6.277

3.  Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.

Authors:  Isabela Werneck Cunha; Katia Candido Carvalho; Waleska Keller Martins; Sarah Martins Marques; Nair Hideko Muto; Roberto Falzoni; Rafael Malagoli Rocha; Samuel Aguiar; Ana C Q Simoes; Lucas Fahham; Eduardo Jordão Neves; Fernando Augusto Soares; Luiz Fernando Lima Reis
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

4.  Involvement of Nuclear Receptor REV-ERBβ in Formation of Neurites and Proliferation of Cultured Adult Neural Stem Cells.

Authors:  Koji Shimozaki
Journal:  Cell Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.046

5.  Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yazhou Li; Harold W Holloway; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Alzheimers Dement       Date:  2015-08-29       Impact factor: 21.566

6.  Repeated small perturbation approach reveals transcriptomic steady states.

Authors:  Ching-Lung Huang; Wun-Yi Shu; Min-Lung Tsai; Chi-Shiun Chiang; Cheng-Wei Chang; Chiu-Ting Chang; Ian C Hsu
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

7.  Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces.

Authors:  R Christopher D Furniss; Wen Wen Low; Despoina A I Mavridou; Laura F Dagley; Andrew I Webb; Edward W Tate; Abigail Clements
Journal:  J Biol Chem       Date:  2018-09-06       Impact factor: 5.157

8.  Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.

Authors:  Michael B Wolfe; Trista L Schagat; Michelle T Paulsen; Brian Magnuson; Mats Ljungman; Daeyoon Park; Chi Zhang; Zachary T Campbell; Aaron C Goldstrohm; Peter L Freddolino
Journal:  RNA       Date:  2020-08-04       Impact factor: 4.942

9.  Immune infiltration landscape and immune-marker molecular typing of pulmonary fibrosis with pulmonary hypertension.

Authors:  Haomin Cai; Hongcheng Liu
Journal:  BMC Pulm Med       Date:  2021-11-25       Impact factor: 3.317

10.  miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Authors:  Andrea Feliciano; Josep Castellvi; Ana Artero-Castro; Jose A Leal; Cleofé Romagosa; Javier Hernández-Losa; Vicente Peg; Angels Fabra; Francisco Vidal; Hiroshi Kondoh; Santiago Ramón Y Cajal; Matilde E Lleonart
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.